Bromodeoxyuridine-mediated radiosensitization in hum glioma: The effect of concentration, duration, and fluoropyrimidine modulation
- Univ. of Michigan Medical Center, Ann Arbor, MI (United States); and others
To define the relative influence of duration of exposure, concentration, and modulation by fluorodeoxyuridines (FdUrd) on the incorporation of 5-bromo-2-deoxyuridine (BrdUrd) into DNA of human malignant glioma line (D-54) in vitro and in vivo. In vitro studies: an established human malignant glioma line (D-54)was exposed to a clinically achievable concentration of BrdUrd to model intravenous (1 {mu}M BrdUrd) and intraarterial (4 {mu}MBrdUrd) conditions. The influence of modulation was assessed using 1 nM FdUrd. Incorporation of BrdUrd, radiosensitization, and cytotoxicity were determined after 24, 72, and 120 h drug exposures. In Vivo studies: nude mice bearing D-54 xenografts were infused with BrdUrd at 100 mg/kg/day for 7 and 14 days or BrdUrd at 400 mg/kg/day for 5 days. The influence of modulation was assessed by combining 100 mg/kg/day of BrdUrd with 0.1, 0.3 and 1 mg/kg/day FdUrd for 7 days. Incorporation of BrddUrd into the DNA of tumor, gut, and marrow were determined. In Vitro: thymidine replacement and radiosensitization were a function of concentration, and incorporation began to plateau after 2 to 3 population doublings. Modulation with 1 nM FdUrd significantly increased incorporation. Radiosensitization was a linear function of thymidine replacement under all conditions tested. In Vivo: infusion with 400 mg/kg/day for 5 days resulted in greater tumor incorporation (10.3 {plus_minus} 0.4% thymidine replaced) than treatment with 100 mg/kg/day for 14 days (6.0 {plus_minus} 0.6% of thymidine replaced) than treatment with 100 mg/kg/day for 14 days for 14 days (6.0 {plus_minus} 0.6% of thymidine replaced). Infusion of FdUrd with BrdUrd increased normal tissue incorporation of BrdUrd, but failed to increase BrdUrd incorporation in tumor cells. These results suggest that relatively short, high dose rate infusions may be preferable to long, low dose rate infusions. 33 refs., 5 figs., 2 tabs.
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 96094
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 30, Issue 3; Other Information: PBD: 15 Oct 1994
- Country of Publication:
- United States
- Language:
- English
Similar Records
5-Iodo-2-Pyrimidinone-2'-Deoxyribose-Mediated Cytotoxicity and Radiosensitization in U87 Human Glioblastoma Xenografts
Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs